300119-基本财务实时评分详情
瑞普生物300119基本财务实时评分详情
更新时间:2021-05-10 00:00:01
股票代码
300119
当期评分
股票名称
瑞普生物
报告日期2018-12-312019-12-312020-09-302020-09-302020-09-302020-09-30
每股经营现金流(¥)0.43230.94840.61020.61020.6102
销售净利润率(%)11.853815.259919.592219.592219.5922
销售毛利率(%)48.717551.11255.443155.443155.4431
净资产收益率(%)5.929.1610.9510.9510.95
营业增长率(%)13.60923.255941.446641.446641.4466
净利润增长率(%)13.057158.672165.557565.557565.5575
每股收益(%)0.29410.48940.37290.18520.6376
现金流量比率(%)26.279736.67679.7057-0.749926.1614
三项费用比重(%)30.025630.276728.83230.600527.4846
每股净资产(¥)4.96965.24595.39375.44225.6961
流动比率(%)2.04571.46481.43671.47131.7063
速动比率(%)1.65751.21281.15051.2331.3542
现金比率(%)43.269537.89542.630824.058824.0588
总资产利润率(%)4.76296.82144.64982.31087.7993
主营利润比重%357.9354288.3997257.4244258.7726243.7196
应收账款(万元)38,107.3634,791.5547,364.0546,772.7450,469.87
应收票据(万元)1,874.35115.68277.82189.20457.50
预付款项(万元)8,050.235,972.286,216.566,723.707,158.17
存货(万元)25,834.5526,363.5032,441.1527,766.7133,220.42
在建工程(万元)14,729.5326,092.8029,025.5927,022.8536,142.75
应付款项(万元)14,385.7015,658.3118,118.6515,333.8417,186.72
长期借款(万元)--------9,025.23
未分配利润(万元)57,654.0774,662.5479,383.3581,975.4189,880.49
商誉(万元)6,780.276,780.276,780.276,780.276,780.27
流动资产(万元)163,707.91203,116.29209,408.79205,176.52216,868.16
流动负债(万元)66,546.29104,592.01113,336.82116,512.2994,344.54
瑞普生物300119评分结果
78.79分
买入/增持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006